Attention-Deficit Hyperactivity Disorder (ADHD)

 

• Attention-Deficit Hyperactivity Disorder (ADHD)

• Attention-deficit hyperactivity disorder (ADHD) is characterized by inattention, impulsivity, and hyperactivity. To be diagnosed, an individual must exhibit six or more symptoms of inattention and six or more hyperactivity/impulsivity symptoms that impair daily life in at least two settings for at least six months.

  
  

  Approximately 3-10% of school-aged children have some aspect of ADHD, whereas 5% of adults have the disorder. Hyperactivity symptoms decline with age; inattention and impulsivity can persist into adulthood.

  Often coexisting with ADHD is bipolar disorder, learning disabilities, depression, anxiety, and substance abuse.

  
  

• Non-stimulant Drugs for ADHD

• Atomoxetine (Strattera) is a non-stimulant alternative that is not a controlled substance and can help with behavioral management.

  
  

  Atomoxetine works by potentiating norepinephrine and/or dopamine in the brain, which helps with focus and curb impulsivity, either on its own or in combination with CNS stimulants.

  
  

  Common side effects include nausea, heartburn, fatigue, and decreased appetite; can cause severe liver injury.